Key result
Cryo-electron microscopy reveals the 3.5 Å structure of SARS-CoV-2 holo-RdRp complexed with nsp13 helicase.
Why the study?
SARS-CoV-2 holo-RdRp and nsp13 helicase are essential for viral replication and serve as targets for COVID-19 treatment.
Answers are grounded in this paper and cite their sources.
The study provides the structural basis for helicase-polymerase coupling in the SARS-CoV-2 replication-transcription complex, detailing a new pocket in the NiRAN domain for potential anti-viral therapeutic development.
SARS-CoV-2 is the causative agent of the 2019-2020 pandemic. The SARS-CoV-2 genome is replicated-transcribed by the RNA-dependent RNA polymerase holoenzyme (subunits nsp7/nsp82/nsp12) along with a cast of accessory factors. One of these factors is the nsp13 helicase. Both the holo-RdRp and nsp13 are essential for viral replication and are targets for treating the disease COVID-19. Here we present cryo-electron microscopic structures of the SARS-CoV-2 holo-RdRp with an RNA template-product in complex with two molecules of the nsp13 helicase. The Nidovirus-order-specific N-terminal domains of each nsp13 interact with the N-terminal extension of each copy of nsp8. One nsp13 also contacts the nsp12-thumb. The structure places the nucleic acid-binding ATPase domains of the helicase directly in front of the replicating-transcribing holo-RdRp, constraining models for nsp13 function. We also observe ADP-Mg2+ bound in the nsp12 N-terminal nidovirus RdRp-associated nucleotidyltransferase domain, detailing a new pocket for anti-viral therapeutic development.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2020) studied SARS-CoV-2. Cryo-electron microscopy was evaluated. Cryo-electron microscopy revealed the 3.5 Å resolution structure of the SARS-CoV-2 holo-RdRp in complex with two molecules of the nsp13 helicase, detailing helicase-polymerase coupling.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: